Ophthalmic Lasers Market by Type - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4333258
  • Report
  • Region: Global
  • 170 pages
  • Allied Analytics LLP
1 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • Carl Ziess Meditec Ag
  • Ellex Medical Corporation
  • Iridex Corporation
  • Lumenis
  • Nidek Co., Ltd.
  • MORE
A laser is a device that emits light and works on the principle of optical amplification based on the stimulated emission of electromagnetic radiation. At present, lasers are highly adopted in the area of medicine for treatment of various diseases. Moreover, these are adopted rapidly in ophthalmology procedures due to their positive results during an eye surgery.

The market for ophthalmic laser is expected to witness significant growth during the forecast period due to increase in number of eye-related diseases, such as glaucoma, cataract, refractive errors, and diabetic retinopathy. Furthermore, advancements in the laser technology and increased awareness of laser applications in the area of ophthalmology are expected to boost the market growth. However, the stringent safety regulations and high rate of failure are expected to restrain the growth. Emerging nations, such as LAMEA and Asia-Pacific, are expected to provide major opportunities to the manufacturers.

The report segments the market based on type, product, application, end user, and region. Based on type, it is classified into photodisruption lasers, selective trabeculoplasty lasers (SLT), and photocoagulation lasers. Based on the product, it is categorized into femtosecond lasers, excimer lasers, Nd:YAG lasers, diode lasers, and others. The application segment is further divided into refractive error, cataract surgery, glaucoma surgery, and others. Based on the end user, the market is categorized into hospitals, ambulatory service centers, and clinics. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
The report offers a quantitative analysis from 2016 to 2023, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis by product elucidates the various types of ophthalmic lasers used for diverse surgical procedures of the eye.
Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

KEY PLAYERS PROFILED

Carl Ziess Meditec Ag
Novartis AG
Topcon Corporation
Ellex Medical Corporation
Quantel Inc.
Iridex Corporation
Nidek Co., LTD.
Lumenis
Abbott Laboratories
Ziemer Ophthalmic Systems

KEY MARKET SEGMENTS

BY TYPE

Photodisruption Lasers
Selective Trabeculoplasty Laser (SLT)
Photocoagulation

BY PRODUCT

Femtosecond Lasers
Excimer Lasers
Nd:YAG Lasers
Diode Lasers
Others

BY APPLICATION

Refractive Error
Cataract Surgery
Glaucoma Surgery
Others

BY END USER

Hospitals
Ambulatory Care Centers
Clinics

BY REGION

North America
U.S.
Canada
Mexico
Europe
France
Germany
UK
Italy
Spain
The Netherlands
Norway
Russia
Sweden
Switzerland
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
New Zealand
Taiwan
Thailand
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Chile
Columbia
Egypt
Iran
Israel
Turkey
Venezuela
Rest of LAMEA

The other players of the dialysis market include (companies not profiled in the report):

Lightmed USA, Coherent, Inc.
Ocular Instruments
Asico LLC.
Deka M.E.L.A. S.r.l.,
NoIR Laser Company, LLC.
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • Carl Ziess Meditec Ag
  • Ellex Medical Corporation
  • Iridex Corporation
  • Lumenis
  • Nidek Co., Ltd.
  • MORE
CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET DYNAMICS

CHAPTER 4 OPHTHALMIC LASERS MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. PHOTODISRUPTIVE LASERS

4.2.1. Market size and forecast

4.3. SELECTIVE TRABECULOPLASTY LASER (SLT)

4.3.1. Market size and forecast

4.4. PHOTOCOAGULATION LASERS

4.4.1. Market size and forecast

CHAPTER 5 OPHTHALMIC LASERS MARKET, BY PRODUCT

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. FEMTOSECOND LASERS

5.2.1. Market size and forecast

5.3. EXCIMER LASERS

5.3.1. Market size and forecast

5.4. NEODYMIUM-DOPED YTTRIUM ALUMINIUM GARNET (ND:YAG) LASERS,

5.4.1. Market size and forecast

5.5. DIODE LASERS

5.5.1. Market size and forecast

5.6. OTHER LASERS

5.6.1. Market size and forecast

CHAPTER 6 OPHTHALMIC LASERS MARKET, BY APPLICATION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. REFRACTIVE ERROR

6.2.1. Market size and forecast

6.3. CATARACT SURGERY

6.3.1. Market size and forecast

6.4. GLAUCOMA SURGERY

6.4.1. Market size and forecast

6.5. OTHERS

6.5.1. Market size and forecast

CHAPTER 7 OPHTHALMIC LASERS MARKET, BY END USER

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. HOSPITALS

7.2.1. Market size and forecast

7.3. AMBULATORY SERVICE CENTRES

7.3.1. Market size and forecast

7.4. EYE CLINICS

7.4.1. Market size and forecast

CHAPTER 8 OPHTHALMIC LASERS MARKET, BY GEOGRAPHY

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. NORTH AMERICA

8.2.1. Key market trends
8.2.2. Key growth factors and opportunity
8.2.3. Market size and forecast
8.2.4. U.S. Market size and forecast
8.2.5. Canada Market size and forecast
8.2.6. Mexico Market size and forecast

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.4. France Market size and forecast
8.3.5. Germany Market size and forecast
8.3.6. UK Market size and forecast
8.3.7. Italy Market size and forecast
8.3.8. Spain Market size and forecast
8.3.9. The Netherlands Market size and forecast
8.3.10. Norway Market size and forecast
8.3.11. Russia Market size and forecast
8.3.12. Sweden Market size and forecast
8.3.13. Switzerland Market size and forecast
8.3.14. Rest of Europe Market size and forecast

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.4. Japan Market size and forecast
8.4.5. China Market size and forecast
8.4.6. India Market size and forecast
8.4.7. Australia Market size and forecast
8.4.8. South Korea Market size and forecast
8.4.9. New Zealand Market size and forecast
8.4.10. Taiwan Market size and forecast
8.4.11. Thailand Market size and forecast
8.4.12. Rest of Asia-Pacific Market size and forecast

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.4. Brazil Market size and forecast
8.5.5. Saudi Arabia Market size and forecast
8.5.6. South Africa Market size and forecast
8.5.7. Chile Market size and forecast
8.5.8. Columbia Market size and forecast
8.5.9. Egypt Market size and forecast
8.5.10. Iran Market size and forecast
8.5.11. Israel Market size and forecast
8.5.12. Turkey Market size and forecast
8.5.13. Venezuela Market size and forecast
8.5.14. Rest of LAMEA Market size and forecast

CHAPTER 9 COMPANY PROFILES

9.1. CARL ZIESS MEDITEC AG

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance
9.1.5. Key strategic moves and developments

9.2. NOVARTIS AG

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance
9.2.5. Key strategic moves and developments

9.3. TOPCON CORPORATION

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Business performance
9.3.5. Key strategic moves and developments

9.4. ELLEX MEDICAL CORPORATION

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Business performance
9.4.5. Key strategic moves and developments

9.5. QUANTEL INC.

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments

9.6. IRIDEX CORPORATION

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Business performance
9.6.5. Key strategic moves and developments

9.7. NIDEK CO., LTD.

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Business performance
9.7.5. Key strategic moves and developments

9.8. LUMENIS

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.8.5. Key strategic moves and developments

9.9. ABBOTT LABORATORIES

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments

9.10. ZIEMER OPHTHALMIC SYSTEMS

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Business performance
9.10.5. Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • Carl Ziess Meditec Ag
  • Ellex Medical Corporation
  • Iridex Corporation
  • Lumenis
  • Nidek Co., Ltd.
  • MORE
According to a new report titled, Ophthalmic lasers market by Type, Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023, the global ophthalmic lasers market was valued at $1,111 million in 2016, and is projected to reach $1,516 million by 2023, registering a CAGR of 4.5% from 2017 to 2023. The photocoagulation lasers segment dominated the global market, accounting for a share of nearly three-fourths of the total market in 2016.
A laser is a device that emits light through a process of optical amplification based on the stimulated emission of electromagnetic radiation. This device is used increasingly in the area of ophthalmology as there is an understanding of laser-tissue interactions in this medical application, such as ophthalmology. This results into use of medical lasers in treating a wide spectrum of eye-related diseases, such as cataract, glaucoma, age-related macular edema, and diabetic retinopathy.
The factors that drive the ophthalmic lasers market are surge in number of eye-related diseases, advancements in the laser technology, and increased awareness for laser application in the area of ophthalmology. However, stringent safety regulations and high rate of failure of surgeries involving use of lasers limit the market growth. Emerging nations, such as LAMEA and Asia-Pacific, and increasing disposable income are expected to provide major opportunities to the manufacturers of ophthalmic lasers.
The Nd:YAG lasers segment is expected to register highest CAGR of 5.2% from 2017 to 2018. This is attributed to diverse applications of these lasers in the treatment of various eye diseases.

Key Findings of the Ophthalmic Lasers Market:
The photodisruption lasers segment is projected to grow at CAGR of 3.0% during the forecast period.
North America accounted for a dominant position in the regional landscape in 2016, accounting for two-fifths share of the total market.
In 2016, the eye clinics segment accounted for a share of more than one-fourth of the total ophthalmic lasers market.
The glaucoma surgery segment accounted for the highest CAGR of 6.6% in the global ophthalmic lasers market, by application in 2016.
In 2016, North America accounted for a share of two-fifths of the global market, owing to the increase in prevalence of eye-related diseases and high adoption of technologically advanced products. Europe holds the second position in the global ophthalmic lasers market.
The major companies profiled in the report include Carl Ziess Meditec Ag, Novartis AG, Topcon Corporation, Ellex Medical Corporation, Quantel Inc., Iridex Corporation, Nidek Co., LTD., Lumenis, Abbott Laboratories, and Ziemer Ophthalmic Systems.
Note: Product cover images may vary from those shown
5 of 6
  • Carl Ziess Meditec Ag
  • Novartis Ag
  • Topcon Corporation
  • Ellex Medical Corporation
  • Quantel Inc.
  • Iridex Corporation
  • Nidek Co., Ltd.
  • Lumenis
  • Abbott Laboratories
  • Ziemer Ophthalmic Systems
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll